TickerFacts.

Company research / EMBC

Embecta Corp. (EMBC)

Build a valuation ↗↓ Download CSV

CIK 0001872789 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Sep 30

For the year ended 2025-09-30, Embecta Corp. reported revenue of $1.08B. Revenue fell 3.8% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.02B.

Key ratios (year ended 2025-09-30)

62.6%
Gross margin
22.4%
Operating margin
8.8%
Net margin
-3.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-08

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-30
Revenue$1.02B$1.08B$1.12B$1.12B$1.13B$1.17B$1.09B
Cost of Revenue$417.40M$403.60M$387.90M$370.90M$354.60M$364.90M$322.90M
Gross Profit$601.30M$676.80M$735.20M$749.90M$774.90M$800.40M$762.60M
R&D Expense$20.20M$37.30M$78.80M$85.20M$66.90M$63.30M$61.40M
Operating Income$223.50M$242.10M$166.80M$221.50M$309.60M$492.00M$486.50M
Depreciation & Amortization$44.20M$40.70M$36.20M$32.60M$31.70M$38.30M$38.30M
EBITDA$267.70M$282.80M$203.00M$254.10M$341.30M$530.30M$524.80M
Net Income$87.50M$95.40M$78.30M$70.40M$223.60M$414.80M$427.60M
EPS (Diluted)n/a$1.62$1.34$1.22$3.89$7.28$7.50
Total Assets$1.27B$1.09B$1.29B$1.21B$1.09B$788.00Mn/a
Long-Term Debtn/a$1.40B$1.57Bn/an/an/an/a
Shareholders' Equity-$612.70M-$650.60M-$738.30M-$821.70M-$891.40M$594.30M$572.20M
Cash & Equivalents$214.70M$225.50M$267.50M$326.30M$330.90M$0n/a
Operating Cash Flow$174.10M$191.70M$35.70M$67.70M$412.20M$456.30M$498.50M
Capital Expenditures$9.50M$9.30M$15.80M$26.50M$23.60M$36.80M$41.90M
Free Cash Flow$164.60M$182.40M$19.90M$41.20M$388.60M$419.50M$456.60M
Dividends Paid$27.20M$35.00M$34.50M$34.40M$8.60M$0$0
Shares Outstanding56.66M58.50M57.71M57.33M57.06Mn/an/a
Dividends Per Sharen/a$0.60$0.60$0.60$0.15n/an/a
Weighted Average Diluted Sharesn/a58.91M58.33M57.76M57.46M57.01M57.01M
EPS (Basic)n/a$1.64$1.36$1.23$3.92$7.28$7.50

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView